220 related articles for article (PubMed ID: 32697042)
21. Prognostic SLC family genes promote cell proliferation, migration, and invasion in hepatocellular carcinoma.
Fang X; Liu Y; Xiao W; Zhao N; Zhu C; Yu D; Zhao Y
Acta Biochim Biophys Sin (Shanghai); 2021 Jul; 53(8):1065-1075. PubMed ID: 34128989
[TBL] [Abstract][Full Text] [Related]
22. Nonionic surfactants modulate the transport activity of ATP-binding cassette (ABC) transporters and solute carriers (SLC): Relevance to oral drug absorption.
Al-Ali AAA; Nielsen RB; Steffansen B; Holm R; Nielsen CU
Int J Pharm; 2019 Jul; 566():410-433. PubMed ID: 31125713
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive analysis of localization of 78 solute carrier genes throughout the subsections of the rat gastrointestinal tract.
Cedernaes J; Olszewski PK; Almén MS; Stephansson O; Levine AS; Fredriksson R; Nylander O; Schiöth HB
Biochem Biophys Res Commun; 2011 Aug; 411(4):702-7. PubMed ID: 21781957
[TBL] [Abstract][Full Text] [Related]
24. Rational exploration of fold atlas for human solute carrier proteins.
Xie T; Chi X; Huang B; Ye F; Zhou Q; Huang J
Structure; 2022 Sep; 30(9):1321-1330.e5. PubMed ID: 35700727
[TBL] [Abstract][Full Text] [Related]
25. Targeting SLC transporters: small molecules as modulators and therapeutic opportunities.
Schlessinger A; Zatorski N; Hutchinson K; Colas C
Trends Biochem Sci; 2023 Sep; 48(9):801-814. PubMed ID: 37355450
[TBL] [Abstract][Full Text] [Related]
26. Solute carrier transporters: emerging central players in tumour immunotherapy.
Chen R; Chen L
Trends Cell Biol; 2022 Mar; 32(3):186-201. PubMed ID: 34511324
[TBL] [Abstract][Full Text] [Related]
27. Transporter-Mediated Drug Delivery.
Gyimesi G; Hediger MA
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770817
[TBL] [Abstract][Full Text] [Related]
28. A widespread role for SLC transmembrane transporters in resistance to cytotoxic drugs.
Girardi E; César-Razquin A; Lindinger S; Papakostas K; Konecka J; Hemmerich J; Kickinger S; Kartnig F; Gürtl B; Klavins K; Sedlyarov V; Ingles-Prieto A; Fiume G; Koren A; Lardeau CH; Kumaran Kandasamy R; Kubicek S; Ecker GF; Superti-Furga G
Nat Chem Biol; 2020 Apr; 16(4):469-478. PubMed ID: 32152546
[TBL] [Abstract][Full Text] [Related]
29. A phylogenetic analysis between humans and D. melanogaster: A repertoire of solute carriers in humans and flies.
Ceder MM; Fredriksson R
Gene; 2022 Jan; 809():146033. PubMed ID: 34673204
[TBL] [Abstract][Full Text] [Related]
30. A Call for Systematic Research on Solute Carriers.
César-Razquin A; Snijder B; Frappier-Brinton T; Isserlin R; Gyimesi G; Bai X; Reithmeier RA; Hepworth D; Hediger MA; Edwards AM; Superti-Furga G
Cell; 2015 Jul; 162(3):478-87. PubMed ID: 26232220
[TBL] [Abstract][Full Text] [Related]
31. Recent advances on the inhibition of human solute carriers: Therapeutic implications and mechanistic insights.
Wright NJ; Lee SY
Curr Opin Struct Biol; 2022 Jun; 74():102378. PubMed ID: 35487145
[TBL] [Abstract][Full Text] [Related]
32. Targeting solute carriers to modulate receptor-ligand interactions.
Sijben HJ; Superti-Furga G; IJzerman AP; Heitman LH
Trends Pharmacol Sci; 2022 May; 43(5):358-361. PubMed ID: 35232590
[TBL] [Abstract][Full Text] [Related]
33. The gene expression of numerous SLC transporters is altered in the immortalized hypothalamic cell line N25/2 following amino acid starvation.
Hellsten SV; Lekholm E; Ahmad T; Fredriksson R
FEBS Open Bio; 2017 Feb; 7(2):249-264. PubMed ID: 28174690
[TBL] [Abstract][Full Text] [Related]
34. Structural prediction of two novel human atypical SLC transporters, MFSD4A and MFSD9, and their neuroanatomical distribution in mice.
Perland E; Hellsten SV; Schweizer N; Arapi V; Rezayee F; Bushra M; Fredriksson R
PLoS One; 2017; 12(10):e0186325. PubMed ID: 29049335
[TBL] [Abstract][Full Text] [Related]
35. High-Throughput Expression and Purification of Human Solute Carriers for Structural and Biochemical Studies.
Raturi S; Li H; Chang YN; Scacioc A; Bohstedt T; Fernandez-Cid A; Evans A; Abrusci P; Balakrishnan A; Pascoa TC; He D; Chi G; Kaur Singh N; Ye M; Li A; Shrestha L; Wang D; Williams EP; Burgess-Brown NA; Dürr KL; Puetter V; Ingles-Prieto A; Sauer DB
J Vis Exp; 2023 Sep; (199):. PubMed ID: 37843272
[TBL] [Abstract][Full Text] [Related]
36. Hum-mPLoc 3.0: prediction enhancement of human protein subcellular localization through modeling the hidden correlations of gene ontology and functional domain features.
Zhou H; Yang Y; Shen HB
Bioinformatics; 2017 Mar; 33(6):843-853. PubMed ID: 27993784
[TBL] [Abstract][Full Text] [Related]
37. Protein binder toolbox for studies of solute carrier transporters.
Gelová Z; Ingles-Prieto A; Bohstedt T; Frommelt F; Chi G; Chang YN; Garcia J; Wolf G; Azzollini L; Tremolada S; Scacioc A; Hansen JS; Serrano I; Droce A; Cuesta Bernal J; Burgess-Brown NA; Carpenter EP; Dürr KL; Kristensen P; Geertsma ER; Štefanić S; Scarabottolo L; Wiedmer T; Puetter V; Sauer DB; Superti-Furga G
J Mol Biol; 2024 Jun; ():168665. PubMed ID: 38878854
[TBL] [Abstract][Full Text] [Related]
38. Solute carriers as potential oncodrivers or suppressors: their key functions in malignant tumor formation.
Rashid K; Ahmad A; Liang L; Liu M; Cui Y; Liu T
Drug Discov Today; 2021 Jul; 26(7):1689-1701. PubMed ID: 33737072
[TBL] [Abstract][Full Text] [Related]
39. The altered renal and hepatic expression of solute carrier transporters (SLCs) in type 1 diabetic mice.
Xu C; Zhu L; Chan T; Lu X; Shen W; Gillies MC; Zhou F
PLoS One; 2015; 10(3):e0120760. PubMed ID: 25789863
[TBL] [Abstract][Full Text] [Related]
40. Solute Carrier Transporters as Potential Targets for the Treatment of Metabolic Disease.
Schumann T; König J; Henke C; Willmes DM; Bornstein SR; Jordan J; Fromm MF; Birkenfeld AL
Pharmacol Rev; 2020 Jan; 72(1):343-379. PubMed ID: 31882442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
